statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	367
CN - Cina	194
NL - Olanda	48
DE - Germania	41
GB - Regno Unito	27
FR - Francia	24
IT - Italia	21
AU - Australia	19
JP - Giappone	17
UA - Ucraina	17
PL - Polonia	16
CA - Canada	15
IN - India	15
HK - Hong Kong	14
IR - Iran	11
ES - Italia	10
BR - Brasile	9
MY - Malesia	8
PE - Perù	7
ZA - Sudafrica	7
IE - Irlanda	6
IL - Israele	6
MX - Messico	6
ID - Indonesia	5
TH - Thailandia	5
TR - Turchia	5
TW - Taiwan	5
PK - Pakistan	4
SE - Svezia	4
SG - Singapore	4
AE - Emirati Arabi Uniti	3
AT - Austria	3
BE - Belgio	3
BG - Bulgaria	3
CL - Cile	3
KR - Corea	3
QA - Qatar	3
VN - Vietnam	3
BD - Bangladesh	2
CO - Colombia	2
DK - Danimarca	2
EC - Ecuador	2
PT - Portogallo	2
RO - Romania	2
RU - Federazione Russa	2
AR - Argentina	1
BA - Bosnia-Erzegovina	1
CM - Camerun	1
CY - Cipro	1
CZ - Repubblica Ceca	1
EG - Egitto	1
FI - Finlandia	1
HU - Ungheria	1
JO - Giordania	1
MA - Marocco	1
ML - Mali	1
NG - Nigeria	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PS - Palestinian Territory	1
SK - Slovacchia (Repubblica Slovacca)	1
UG - Uganda	1
ZW - Zimbabwe	1
Totale	993

Nome	#
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses, file e291c0d9-013b-cddb-e053-3a05fe0aa144	714
Computational studies of mutations associated to resistance in HIV-1 macromolecular targets and implications in rational design of novel antiviral agents, file e291c0d3-6884-cddb-e053-3a05fe0aa144	153
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile, file 84dab908-161c-49c1-a9ee-ecf983c9f7fe	76
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control, file e291c0d8-ef3e-cddb-e053-3a05fe0aa144	62
Computational studies of mutations associated to resistance in HIV-1 macromolecular targets and implications in rational design of novel antiviral agents, file e291c0d3-6885-cddb-e053-3a05fe0aa144	17
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses, file 32b8fdbc-cc97-4bb2-b323-db5ad2f22570	14
Totale	1.036

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	2	0	0	0	0	0	0	0	0	0	0	2	0
2019/2020	8	1	5	0	0	0	0	1	0	1	0	0	0
2020/2021	270	1	3	0	0	0	0	19	24	46	64	55	58
2021/2022	421	59	56	55	109	77	9	9	7	13	1	17	9
2022/2023	115	2	6	15	10	17	7	10	8	12	7	14	7
2023/2024	96	3	14	4	4	10	1	13	7	17	11	12	0
Totale													1.036